In ovarian cancer, DAC upregulated miR-199, which suppressed tumor growth and enhanced cytotoxicity of cisplatin in vitro and in vivo by shutting down JAG1 mRNA and its overexpression, thus suggesting the targeting of chromatin remodelers to indirectly modulate Notch signaling with miRNAs [315]. The gene discussed is JAG1; the disease is neoplasm.